JPH08238299A - Medical container - Google Patents
Medical containerInfo
- Publication number
- JPH08238299A JPH08238299A JP7070686A JP7068695A JPH08238299A JP H08238299 A JPH08238299 A JP H08238299A JP 7070686 A JP7070686 A JP 7070686A JP 7068695 A JP7068695 A JP 7068695A JP H08238299 A JPH08238299 A JP H08238299A
- Authority
- JP
- Japan
- Prior art keywords
- container
- drug
- communication
- medical
- passage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 169
- 229940079593 drug Drugs 0.000 claims abstract description 148
- 238000004891 communication Methods 0.000 claims abstract description 110
- 230000001954 sterilising effect Effects 0.000 claims description 45
- 238000004659 sterilization and disinfection Methods 0.000 claims description 43
- 229920005989 resin Polymers 0.000 claims description 28
- 239000011347 resin Substances 0.000 claims description 28
- 230000000903 blocking effect Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 5
- 239000012530 fluid Substances 0.000 abstract 5
- 239000000243 solution Substances 0.000 description 55
- 239000007788 liquid Substances 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 238000001802 infusion Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- -1 dissolution Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 229920001684 low density polyethylene Polymers 0.000 description 3
- 239000004702 low-density polyethylene Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920013716 polyethylene resin Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000012865 aseptic processing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、点滴注射等に用いられ
る薬剤とその溶解、希釈、或は混合薬等の薬液とを無菌
的に混合するために除菌フィルタを取り付けた医療用容
器に関するものである。ここで、薬剤とは粉末等の固形
剤に限らず液剤を含み、薬液とは、薬剤の希釈液、溶解
液、及び混合用薬液等をいう。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical container equipped with a sterilizing filter for aseptically mixing a drug used for drip injection or the like with a drug solution such as dissolution, dilution or mixed drug. It is a thing. Here, the drug includes not only a solid agent such as powder but also a liquid agent, and the drug solution refers to a diluting solution, a solution, and a mixing drug solution of the drug.
【0002】[0002]
【従来の技術】従来より、水溶液の状態では非常に不安
定な薬剤は、粉末状の薬剤としてゴム栓付きのバイアル
等に保存されている。これらの薬剤を患者に投与するに
は、薬剤容器に注射器等で溶解液を注入し、薬剤を溶解
させた後再び注射器等で薬剤容器から薬剤が溶解した液
を取り出し、輸液容器に混注して用いられていた。ま
た、高圧蒸気滅菌等の熱による滅菌処理を行うと分解や
変質等を起こす液剤等を無菌的に収容した薬剤容器を使
用する場合も同様である。2. Description of the Related Art Conventionally, a drug which is very unstable in an aqueous solution is stored as a powdered drug in a vial having a rubber stopper. To administer these drugs to patients, inject the solution into the drug container with a syringe, etc., dissolve the drug, and then take out the solution with the drug dissolved again from the drug container with a syringe etc. and mix it into the infusion container. Was used. The same applies to the case of using a drug container that aseptically contains a liquid agent or the like that decomposes or deteriorates when sterilized by heat such as high-pressure steam sterilization.
【0003】しかしながら、これらの一連の操作では、
連通針等を外界に晒すケースが多くなり院内感染の機会
を多くする原因となる。また薬剤によっては無菌処理が
できないものがあり、単純に溶解液に薬剤を溶解して輸
液容器に混注したのでは問題が生じる。そこで、溶解液
或は薬液を収容した容器として薬剤を収容したバイアル
にできる限り無菌的に連結する連結部を備えたものが従
来から提案されている。かかる連結部はバイアル等の容
器に接続する連通針やゴム栓等の接続手段を備え、接続
部の連通針やゴム栓面は使用前まで無菌的なシールがな
されている。このため、使用時には、溶解液の収容容器
内と薬剤の収容容器内をできる限り無菌的に連通し、溶
解液が薬剤に無菌的に流入できるようにしている。However, in these series of operations,
In many cases, the communication needle is exposed to the outside world, which increases the chances of nosocomial infection. In addition, some drugs cannot be subjected to aseptic processing, and a problem occurs if the drugs are simply dissolved in a solution and mixed and injected into an infusion container. Therefore, there has been conventionally proposed a container containing a solution or a drug solution, which is provided with a connecting portion for connecting a vial containing a drug as sterilely as possible. The connecting portion is provided with connecting means such as a communicating needle or a rubber stopper for connecting to a container such as a vial, and the connecting needle and the rubber stopper surface of the connecting portion are aseptically sealed before use. For this reason, at the time of use, the inside of the container for storing the dissolution liquid and the container for storing the drug are communicated as sterilely as possible so that the dissolution liquid can aseptically flow into the drug.
【0004】しかし、このような連結部を備えた容器で
あっても、接続手段において外界に一部晒される機会が
あるため、完全無菌とは言い難い。このため、本願出願
人は先に連結部に除菌フィルタを設け、溶解液を薬剤側
に流入した後に再び除菌フィルタを通して溶解液側の容
器に戻して完全な無菌混注液にする除菌フィルタ付きの
連結部を有した輸液容器を提案している(特願平4−2
38959号)。However, even a container provided with such a connecting portion cannot be said to be completely sterile because there is a chance that the connecting means will be partially exposed to the outside world. Therefore, the applicant of the present application first provided a sterilization filter at the connection portion, and after the lysate flowed into the drug side, it was returned again to the lysate side container through the sterilization filter to make a completely sterile mixed injection liquid sterilization filter. Has proposed a liquid transfusing container having a connecting portion (see Japanese Patent Application No. 4-2.
38959).
【0005】[0005]
【発明が解決しようとする課題】しかしながら、かかる
除菌フィルタを備えた医療用容器では、溶解液等が除菌
フィルタを通過し薬剤容器に流入し、再び、薬液容器に
戻すが、かかる操作には除菌フィルタに薬液を2回通過
させるため時間がかかるという不都合がある。特に、バ
イアル等の定型薬剤容器にあっては陽圧化が生じ、薬液
は徐々に流入し難くなる。またこのような従来のもので
は、薬液及び薬剤の混合操作後、点滴が行われるため、
緊急を要する場合は不都合が生じる。従って、本発明の
目的は、薬剤と薬液とが迅速に混合され、無菌的に容器
内に戻すことのできる医療用容器を提供することにあ
る。However, in a medical container equipped with such a sterilization filter, a lysate or the like passes through the sterilization filter and flows into the drug container, and then is returned to the drug solution container again. Has the inconvenience that it takes time because the chemical solution is passed through the sterilization filter twice. In particular, in a fixed-form drug container such as a vial, positive pressure is generated, and it becomes difficult for the drug solution to gradually flow in. Further, in such a conventional one, since the drip is performed after the mixing operation of the drug solution and the drug,
In case of emergency, inconvenience occurs. Therefore, an object of the present invention is to provide a medical container in which a drug and a drug solution are rapidly mixed and can be aseptically returned into the container.
【0006】[0006]
【課題を解決するための手段】本発明は、薬剤容器との
連通手段を有した非定型性の樹脂容器本体からなり、且
つ上記容器本体内の薬液の一部が薬剤容器内に流入され
て該薬剤と混合された後、再び該薬液が上記容器本体内
に戻される医療用容器において、上記容器本体と薬剤容
器とを連通させた連通路に除菌フィルタが設けられると
共に、上記除菌フィルタを避けて上記容器本体内と薬剤
容器内とを結ぶバイパス路が設けられ、上記薬剤容器に
上記連通手段で接続した際に、上記容器本体の薬液の一
部が上記薬剤容器内に上記バイパス路を介して流入しう
ると共に、再び上記薬液が戻る際に、上記バイパス路が
閉止しうることを特徴とする医療用容器を提供すること
により、上記目的を達成したものである。SUMMARY OF THE INVENTION The present invention comprises an atypical resin container body having means for communicating with a drug container, wherein a part of the drug solution in the container body is introduced into the drug container. In a medical container in which the drug solution is returned to the container body again after being mixed with the drug, a sterilizing filter is provided in a communication passage that connects the container body and the drug container, and the sterilizing filter is also provided. A bypass passage connecting the inside of the container body and the inside of the medicine container is provided, and when the medicine container is connected to the medicine container by the communication means, a part of the liquid medicine in the container body is in the medicine container. The above object is achieved by providing a medical container characterized in that the bypass passage can be closed when the chemical liquid returns again while being able to flow in through.
【0007】本発明には、上記バイパス路は、上記容器
本体に直接連通するバイパスラインからなり、該ライン
が除菌フィルタと上記薬剤容器との間の連通路に接続さ
れているものがある。また上記バイパスラインの開閉を
する遮断部材が連絡路に設けられたものがある。また上
記バイパスラインが可撓性のラインからなり、把持治具
により液密に閉止されうるものがある。In the present invention, the bypass passage may be a bypass line that directly communicates with the container body, and the line is connected to a communication passage between the sterilization filter and the drug container. Further, there is one in which a blocking member for opening and closing the bypass line is provided in the communication path. In addition, the bypass line may be a flexible line that can be liquid-tightly closed by a holding jig.
【0008】本発明にはまた、上記バイパス路は、上記
連通路に移動可能に取付けられる連通材からなり、上記
連通材は、先端に上記薬剤容器に連通する連通針部を有
し、該連通材の所定量の移動により上記針部が上記薬剤
容器へ刺針すると共に、上記容器本体内と薬剤容器とが
直接連通するものがある。Further, in the present invention, the bypass passage is made of a communicating member movably attached to the communicating passage, and the communicating member has a communicating needle portion at a tip thereof which communicates with the medicine container, and the communicating member has a communicating needle portion. In some cases, the needle portion pierces the drug container by moving a predetermined amount of the material, and the inside of the container body and the drug container directly communicate with each other.
【0009】本発明においては、上記薬剤容器が非定型
性を有する樹脂容器であることを特徴とすることができ
る。本発明においてはまた、上記薬剤容器が定型性を有
する容器であって、上記薬剤容器或は上記連通路に外部
と連通するエア抜けエア導入開口が形成されると共に、
該開口にエアフィルタが設けられることを特徴とするこ
とができる。The present invention can be characterized in that the medicine container is a resin container having an atypical shape. In the present invention, the drug container is a container having a typical shape, and the drug container or the communication passage is formed with an air release air introduction opening communicating with the outside,
The opening may be provided with an air filter.
【0010】本発明には更に、上記除菌フィルタと上記
容器本体とを結ぶ連通路の連通口が上記容器本体内の排
出口付近に配されているものがある。Further, according to the present invention, there is one in which a communication port of a communication path connecting the sterilization filter and the container body is arranged in the container body in the vicinity of the discharge port.
【0011】[0011]
【作用】上記医療用容器では、先ず、容器本体に取付ら
れた連通手段、例えば連通路の連通針部を介して薬剤容
器に接続する。そして、バイパス路を利用して医療用容
器内の薬液を迅速に薬剤容器内に流入し薬剤と混合す
る。再び、流入した薬液を再び戻す場合は、バイパス路
を閉止した状態で、医療用容器の本体を下方に配して除
菌フィルタを介して医療用容器内に戻す。従って、薬剤
容器側へ薬液を移行する往路は除菌フィルタを通過しな
いため、極めて短時間での薬剤との混合が可能となる。
そして、再び戻す薬液は除菌フィルタによって無菌状態
で容器本体内に戻る。In the above medical container, first, it is connected to the drug container through the communication means attached to the container body, for example, the communication needle portion of the communication passage. Then, the drug solution in the medical container is promptly flown into the drug container and mixed with the drug using the bypass passage. When returning the inflowing drug solution again, the main body of the medical container is placed below with the bypass passage closed and returned to the inside of the medical container through the sterilization filter. Therefore, since the outward path for transferring the drug solution to the drug container side does not pass through the sterilization filter, it is possible to mix with the drug in an extremely short time.
Then, the chemical liquid to be returned again is returned to the inside of the container body in an aseptic state by the sterilization filter.
【0012】また、薬剤容器が定型性のものであれば、
連通路又は薬剤容器の一部にエアフィルタを備えた開口
を設けるだけで、薬剤容器側の負圧化等を防止すること
ができ、かかる定型性容器の場合もスムーズに医療用容
器側に戻る。更に、上記除菌フィルタと医療容器内とを
連通するためのパイプ等の連通口を医療用容器の排出口
付近に配することにより、薬液の戻り操作と同時に点滴
操作を円滑に行うことができる。即ち、戻り薬液が連通
パイプに案内されて排出口付近に流出してくるため、排
出口付近で戻り薬液が希釈され、排出口から点滴液とし
てスムーズに排出され、混合操作と点滴操作とが同時に
行われ操作時間が短縮する。If the drug container has a typical shape,
It is possible to prevent negative pressure on the drug container side simply by providing an opening provided with an air filter in the communication passage or a part of the drug container, and even in the case of such a regular container, it smoothly returns to the medical container side. . Furthermore, by arranging a communication port such as a pipe for communicating the sterilization filter and the inside of the medical container near the discharge port of the medical container, it is possible to smoothly perform the drip operation simultaneously with the returning operation of the chemical solution. . That is, since the return chemical is guided by the communication pipe and flows out near the discharge port, the return chemical is diluted near the discharge port and is smoothly discharged as a drip solution from the discharge port, so that the mixing operation and the drip operation are performed at the same time. The operation time is shortened.
【0013】[0013]
【実施例】以下、本発明に係る医療用容器の好ましい実
施例を添付図面を参照しながら詳述する。図1は本発明
に係る医療用容器の第一実施例の正断面図、図2は第一
実施例の医療用容器に接続される薬剤容器の正断面図、
図3は第一実施例の医療用容器を薬剤容器に接続して薬
液を薬剤容器に流入する際の要部断面図、図4は薬剤容
器内の薬液を再び第一実施例の医療用容器内に流入する
際の要部断面図である。The preferred embodiments of the medical container according to the present invention will be described below in detail with reference to the accompanying drawings. 1 is a front sectional view of a first embodiment of a medical container according to the present invention, and FIG. 2 is a front sectional view of a drug container connected to the medical container of the first embodiment,
FIG. 3 is a cross-sectional view of essential parts when the medical container of the first embodiment is connected to a drug container and a drug solution flows into the drug container, and FIG. 4 shows the drug solution in the drug container again in the medical container of the first embodiment. It is a principal part sectional view at the time of flowing in.
【0014】本発明に係る第一実施例の医療用容器1は
図1及び図3に示す如く、薬剤容器15との連通手段で
ある連通パイプ6及び連通路10を有した非定型性の樹
脂容器本体2からなり、容器本体2内の薬液3の一部が
薬剤容器15内に流入されて薬剤16と混合された後、
再び薬液3が容器本体2内に戻される容器である。医療
用容器1は、容器本体2と薬剤容器15とを連通させた
連通パイプ6及び連通路10に除菌フィルタ8が設けら
れると共に、除菌フィルタ8を避けて容器本体2内と薬
剤容器15内とを結ぶバイパスライン7が設けられ、薬
剤容器15に連通路10の連通針部10Aで接続した際
に、容器本体2の薬液3の一部が薬剤容器15内にバイ
パスライン7を介して流入しうると共に、再び薬液3が
戻る際に、バイパスライン7が閉止しうるものである。
そして、バイパスライン7が除菌フィルタ8と薬剤容器
15との間の連通路10に接続されている。As shown in FIGS. 1 and 3, the medical container 1 according to the first embodiment of the present invention is an atypical resin having a communication pipe 6 and a communication passage 10 which are means for communicating with the drug container 15. It is composed of the container body 2, and a part of the drug solution 3 in the container body 2 flows into the drug container 15 and is mixed with the drug 16.
It is a container in which the drug solution 3 is returned to the container body 2 again. The medical container 1 is provided with a sterilization filter 8 in the communication pipe 6 and the communication passage 10 that connect the container body 2 and the medicine container 15 to each other, and avoids the sterilization filter 8 and the inside of the container body 2 and the medicine container 15 A bypass line 7 that connects the inside and the inside is provided, and when the drug container 15 is connected by the communication needle portion 10A of the communication passage 10, a part of the drug solution 3 in the container body 2 enters the drug container 15 via the bypass line 7. The bypass line 7 can be closed when it can flow in and the chemical liquid 3 returns again.
The bypass line 7 is connected to the communication passage 10 between the sterilization filter 8 and the medicine container 15.
【0015】本実施例に係る医療用容器1を更に詳しく
説明すると、医療用容器1の容器本体2は、非定型性の
柔軟な樹脂容器からなる。本実施例において具体的に
は、容器本体2は、低密度ポリエチレンをインフレーシ
ョン成形により作製したチューブから形成される。即
ち、かかるチューブが所定の長さに裁断され、その上下
端が熱融着シールされる。上端2Aには連通パイプ6及
びバイパスライン7が取り付けられ、下端2Bには排出
口4が取り付けられて製造される。The medical container 1 according to this embodiment will be described in more detail. The container body 2 of the medical container 1 is an atypical flexible resin container. Specifically, in this embodiment, the container body 2 is formed of a tube made of low density polyethylene by inflation molding. That is, the tube is cut into a predetermined length, and the upper and lower ends thereof are heat-sealed. A communication pipe 6 and a bypass line 7 are attached to the upper end 2A, and a discharge port 4 is attached to the lower end 2B.
【0016】また本実施例では、低密度ポリエチレンを
樹脂容器にも用いたが、可撓性の熱シール可能な樹脂容
器であれば、かかる樹脂に限ることはなく、例えば、直
鎖状低密度ポリエチレン樹脂、高密度ポリエチレン樹
脂、ポリプロピレン樹脂、軟質ポリエステル樹脂、塩素
化ポリエチレン樹脂、塩化ビニル樹脂、エチレン−酢酸
ビニル共重合体等の可撓性に富んだ材料を用いることが
できる。但し容器本体2内には、薬剤の溶解液、混合薬
液、輸液等の薬液3が収容されるため、なかでも、低密
度ポリエチレン樹脂、直鎖状低密度ポリエチレン樹脂、
ポリプロピレン樹脂等のポリオレフィン系樹脂は、耐薬
品性に優れ、溶解液中への溶出物も少なく、廉価であり
経済性に優れているので好ましい。In this embodiment, low-density polyethylene was also used for the resin container, but it is not limited to such resin as long as it is a flexible heat-sealable resin container. A highly flexible material such as polyethylene resin, high-density polyethylene resin, polypropylene resin, soft polyester resin, chlorinated polyethylene resin, vinyl chloride resin, or ethylene-vinyl acetate copolymer can be used. However, since the drug solution 3 such as a drug solution, a mixed drug solution, and an infusion solution is contained in the container body 2, among them, a low-density polyethylene resin, a linear low-density polyethylene resin,
Polyolefin resins such as polypropylene resin are preferable because they are excellent in chemical resistance, have little eluate in the solution, are inexpensive, and are excellent in economic efficiency.
【0017】容器本体2内には、排出口4から薬液3が
充填され、ゴム栓体5で封がされた後にオートクレーブ
滅菌される。薬液3は輸液用の基本液であり、後述する
薬剤容器15内の薬剤を溶解、希釈或は混合等するもの
である。具体的には、アミノ酸液、グルコースが主体の
高カロリー輸液の基本液、生理食塩水、5%ブドウ糖
液、注射用蒸留水のほか、各種電解質を含む溶液等が用
いられる。The container body 2 is filled with the chemical liquid 3 from the outlet 4, sealed with a rubber stopper 5, and then sterilized by autoclaving. The chemical liquid 3 is a basic liquid for infusion, and dissolves, dilutes, or mixes the drug in the drug container 15 described later. Specifically, an amino acid solution, a basic solution for high-calorie infusion mainly containing glucose, physiological saline, 5% glucose solution, distilled water for injection, and a solution containing various electrolytes are used.
【0018】排出口4は樹脂成形材からなり、容器本体
2の熱融着部2Bにあって液密に取り付けられている。
排出口4は先端部でゴム栓5に閉塞され、ゴム栓5は点
滴用の連通針等が刺針可能と成っている。連通パイプ6
は樹脂成形物であり、容器本体2の熱融着部2Aにあっ
て液密に取り付けられている。連通パイプ6の一端部は
後述する除菌フィルタに連結され、他端は容器本体2内
の排出口4付近に配される。また、連通パイプ6の他端
は閉止され、その側周壁に切れ込みが形成されて易開封
機構6Aが形成され、易開封部6Aは、保存時において
連通パイプ6内に薬液3が侵入するのを防止し、使用時
において連通パイプ6内を容易に開放できるようにして
いる。The discharge port 4 is made of a resin molding material and is liquid-tightly attached to the heat-sealed portion 2B of the container body 2.
The outlet 4 is closed by a rubber stopper 5 at its tip, and the rubber stopper 5 can be pierced by a communication needle for drip or the like. Communication pipe 6
Is a resin molded product, which is liquid-tightly attached to the heat-sealed portion 2A of the container body 2. One end of the communication pipe 6 is connected to a sterilization filter which will be described later, and the other end is arranged in the container body 2 near the discharge port 4. Further, the other end of the communication pipe 6 is closed, a cut is formed in the side peripheral wall thereof to form the easy-open mechanism 6A, and the easy-open portion 6A prevents the chemical solution 3 from entering the communication pipe 6 during storage. The inside of the communication pipe 6 can be easily opened during use.
【0019】バイパスライン7は可撓性の樹脂成形物で
あり、容器本体2の熱融着部2Aにあって液密に取り付
けられている。バイパスライン7の一端部は後述する連
通針部10Aを備えた連通路10に接続され、他端の開
口は容器本体2内に配される。尚、本実施例において
は、排出口4、及び連通パイプ6は、ポリプロピレンの
成形物であるが、これに限る必要はなく、その他の汎用
性のある樹脂の使用であっても良い。The bypass line 7 is a flexible resin molded product, which is attached to the heat-sealed portion 2A of the container body 2 in a liquid-tight manner. One end of the bypass line 7 is connected to a communication passage 10 having a communication needle portion 10A described later, and the opening at the other end is arranged in the container body 2. In this embodiment, the outlet 4 and the communication pipe 6 are polypropylene molded products, but the present invention is not limited to this, and other versatile resins may be used.
【0020】上述の除菌フィルタ8は、両面に樹脂成形
物からなる一対のハウジング部材9、9を備え、また図
示しないが除菌フィルタ8の両面を支持する支持ネット
を備えている。一対のハウジング9、9は除菌フィルタ
8の周縁を挟んで熱融着される。ハウジング9内は上述
の連通パイプ6と連通して連結される。また、連通パイ
プ6の反対側のハウジング9内は上述の連通路10が連
結される。The above-mentioned sterilization filter 8 is provided with a pair of housing members 9 made of resin molding on both sides, and a support net (not shown) for supporting both sides of the sterilization filter 8. The pair of housings 9 and 9 are heat-sealed with the peripheral edge of the sterilization filter 8 sandwiched therebetween. The inside of the housing 9 is connected to communicate with the communication pipe 6 described above. Further, the above-mentioned communication passage 10 is connected to the inside of the housing 9 on the opposite side of the communication pipe 6.
【0021】除菌フィルタ8はメンブレンフィルタから
なるが、一般的なスクリーンタイプ、デプスタイプ、ア
ニソトロピックタイプ等の一般フィルタ等も使用でき
る。またフィルタ8の膜の孔径は、0.6μm以下、好
ましくは0.45μm以下、更に好ましくは0.22μ
m以下である。上記範囲内の孔径であれば、細菌の通過
をほぼ完全に阻止し、更に0.45μm以下では細菌の
破片等の毒性成分の除去ができ、0.22μm以下では
破片等の毒性成分を殆ど除去しうる。The sterilization filter 8 is a membrane filter, but general screen type, depth type, anisotropic type general filters and the like can also be used. The pore diameter of the membrane of the filter 8 is 0.6 μm or less, preferably 0.45 μm or less, more preferably 0.22 μm.
m or less. If the pore size is within the above range, the passage of bacteria is almost completely prevented, and if 0.45 μm or less, toxic components such as bacterial debris can be removed, and if 0.22 μm or less, most toxic components such as debris are removed. You can.
【0022】除菌フィルタ8の素材は親水性のものが使
用される。親水性フィルタとしては、親水化処理したポ
リビニリデンフロライド等を用いているが、一般的に代
表される、酢酸セルロース、セルロースエステル、硝酸
セルロース、再生セルロース等セルロース系膜、ナイロ
ン等を中心としたポリアミド系膜、粉末或は分散媒中の
フッ化エチレン系樹脂等から製造されるテフロン系膜、
ポリスチレン、フタル酸等からなるビニル系膜、結晶性
ポリプロピレン等を融解押出し急速延伸等して得られる
ポリオレフィン系膜、アクリル系膜、ポリカーボネート
系膜、塩化ビニリデン系膜などの親水性フィルタとして
使用されるものが用いられる。また、合成樹脂素材に限
らず場合によっては、天然のフィルタ材を使用しても良
い。The material of the sterilization filter 8 is hydrophilic. As the hydrophilic filter, polyvinylidene fluoride or the like which has been hydrophilized is used, but typically, cellulose acetate, cellulose ester, cellulose nitrate, regenerated cellulose and other cellulose-based membranes, mainly nylon, etc. Polyamide-based film, Teflon-based film manufactured from fluorinated ethylene resin in powder or dispersion medium,
Used as a hydrophilic filter for polyolefin membranes such as vinyl membranes made of polystyrene and phthalic acid, crystalline polypropylene, etc., obtained by melt extrusion and rapid stretching, acrylic membranes, polycarbonate membranes, vinylidene chloride membranes, etc. Things are used. Further, not only synthetic resin material but also natural filter material may be used depending on the case.
【0023】連通路10は樹脂成形物であり、先端部に
連通針部10Aが形成される。連通針部10A内には通
路を二つに分ける仕切り壁11が形成され、仕切り壁1
1は薬液3の流路とエアの流路が形成されるように作用
している。連通路10の側壁にはバイパスライン7の為
の開口12が形成され、開口12は遮断部材13により
開閉される。遮断部材13は、両端にフランジを有した
筒状の樹脂成形物であり、連通路10に外嵌し連通路1
0の軸方向にスライド可能に設けられる。遮断部材13
にはバイパスライン7の先端が取り付けられ、その取付
部分には接続用開口14が形成される。遮断部材13が
軸方向にスライドすることにより、連通路10の開口1
2と遮断部材13の接続用開口14が合わさり、バイパ
スライン7が連通路10と連通される。The communication passage 10 is a resin molded product, and the communication needle portion 10A is formed at the tip. A partition wall 11 that divides the passage into two is formed in the communication needle portion 10A.
1 acts so that a flow path for the chemical liquid 3 and a flow path for air are formed. An opening 12 for the bypass line 7 is formed on the side wall of the communication passage 10, and the opening 12 is opened and closed by a blocking member 13. The blocking member 13 is a tubular resin molded product having flanges at both ends, and is fitted onto the communication passage 10 so as to be externally fitted thereto.
It is slidable in the axial direction of 0. Blocking member 13
The front end of the bypass line 7 is attached to the connector, and a connection opening 14 is formed in the attached portion. When the blocking member 13 slides in the axial direction, the opening 1 of the communication passage 10
2 and the connection opening 14 of the blocking member 13 are brought together to allow the bypass line 7 to communicate with the communication passage 10.
【0024】図2に示す如く本実施例に使用される薬剤
容器15は、医療用容器本体2と同様に可撓性の柔軟性
のある樹脂よりなる。薬剤容器15は容器本体2と同様
にインフレーシュン成形されたチューブの両端をシール
して形成される。薬剤16はゴム栓17を有した取出口
18から無菌的に充填され、取出口18は樹脂成形物か
らなり、熱融着により液密に容器15に取り付けられ
る。薬剤16は粉末の抗性物質である。しかし、本実施
例にあっては、薬剤を粉末に限る必要はなく液剤であっ
ても良い。また具体的な液剤としては、アミノ酸の一種
であるグルタミン酸がある。特に、グルタミン酸水溶液
を100℃に加熱すると一部ヒロリドン化し変質してし
まうので、高圧蒸気滅菌ができない。このように水溶液
の状態で滅菌できない薬剤も対象となる。As shown in FIG. 2, the drug container 15 used in this embodiment is made of a flexible resin similar to the medical container body 2. Similar to the container body 2, the drug container 15 is formed by sealing both ends of an inflation-molded tube. The chemical 16 is aseptically filled from an outlet 18 having a rubber stopper 17, and the outlet 18 is made of a resin molding and is liquid-tightly attached to the container 15 by heat fusion. Drug 16 is a powdered anti-drug. However, in the present embodiment, the drug is not limited to powder and may be liquid. A specific liquid agent is glutamic acid, which is a type of amino acid. Particularly, when the aqueous solution of glutamic acid is heated to 100 ° C., it is partially converted into hirolidone and deteriorates, so that high-pressure steam sterilization cannot be performed. Drugs that cannot be sterilized in the state of an aqueous solution are also targeted.
【0025】次に、図3及び図4に従って本実施例の医
療用容器1の使用について説明する。先ず、医療用容器
1は転倒され、連通路10の連通針部10Aが薬剤容器
15のゴム栓17に刺針され、連通路10内と薬剤容器
15内が連通される。次に、遮断部材13が下にスライ
ドされ、連通路10内とバイパスライン7内とが連通さ
れる。これにより、容器本体2内の薬液3は、図3の矢
印Aの方向に従って薬剤容器15内に所定量が速やかに
流入される。薬液3の流入が完了したとき、遮断部材1
3が元の位置までスライドされ、バイパスライン7と連
通路10との間が閉塞される。Next, the use of the medical container 1 of this embodiment will be described with reference to FIGS. First, the medical container 1 is inverted, and the communication needle portion 10A of the communication passage 10 is pierced by the rubber stopper 17 of the medicine container 15 to communicate the inside of the communication passage 10 and the inside of the medicine container 15. Next, the blocking member 13 is slid downward so that the inside of the communication passage 10 and the inside of the bypass line 7 communicate with each other. As a result, a predetermined amount of the drug solution 3 in the container body 2 quickly flows into the drug container 15 according to the direction of arrow A in FIG. When the inflow of the chemical liquid 3 is completed, the blocking member 1
3 is slid back to the original position, and the bypass line 7 and the communication passage 10 are closed.
【0026】薬剤容器15内で薬剤16と薬液3とが十
分に混合された後、容器本体2は薬剤容器15と共に再
び転倒され、薬剤容器15が容器本体2の上方に配され
る。かかる状態で、薬剤容器15等が吊され、点滴用の
連通針19が排出口4のゴム栓5に刺針される。そし
て、連結パイプ6の易開封部6Aが折り取られ、連通パ
イプ6内が容器本体2内と連通される。After the drug 16 and the drug solution 3 are sufficiently mixed in the drug container 15, the container body 2 is turned over together with the drug container 15, and the drug container 15 is arranged above the container body 2. In this state, the drug container 15 and the like are suspended, and the communication needle 19 for drip is pierced into the rubber stopper 5 of the discharge port 4. Then, the easily opened portion 6A of the connection pipe 6 is broken off, and the inside of the communication pipe 6 is connected to the inside of the container body 2.
【0027】薬剤容器15内で混合された薬液3は連通
路10を通過して除菌フィルタ8のハウジング9内に流
れる。薬液3は除菌フィルタ8で除菌されて下方のハウ
ジング9内に流入し、連結パイプ6を通過して容器本体
2内の排出口4の近傍に徐々に流出する。流出した薬剤
16を含む薬液3は周りの薬液により希釈されて点滴用
の連通針19内に流入し、その結果、薬液3と薬剤16
との混合操作と同時に点滴がなされる。従って、混合、
点滴操作においては、薬液3と薬剤15と迅速に混合
し、その混合薬液3が除菌フィルタ8により無菌的に容
器本体2内に戻る。また、除菌フィルタ8での戻り操作
と共に、点滴が可能なため点滴操作に無駄が生じない。The drug solution 3 mixed in the drug container 15 passes through the communication passage 10 and flows into the housing 9 of the sterilization filter 8. The chemical liquid 3 is sterilized by the sterilization filter 8, flows into the lower housing 9, passes through the connecting pipe 6, and gradually flows out to the vicinity of the discharge port 4 in the container body 2. The drug solution 3 containing the drug 16 that has flowed out is diluted by the drug solution around and flows into the communication needle 19 for infusion, and as a result, the drug solution 3 and the drug 16
The drip is made at the same time as the mixing operation with. Therefore, mixing,
In the drip operation, the drug solution 3 and the drug 15 are rapidly mixed, and the mixed drug solution 3 is aseptically returned to the container body 2 by the sterilization filter 8. Further, since the drip can be performed at the same time as the returning operation in the sterilization filter 8, the drip operation is not wasted.
【0028】図5は、本実施例の医療用容器1の変形例
である。かかる変形例では、バイパスライン7にスライ
ド用の遮断部材13を設ける変わりに、バイパスライン
7を液密に閉塞する把持治具であるクランプ51を設け
たものである。このような構成にあっても、本実施例の
作用効果を十分に奏しうるものである。FIG. 5 shows a modification of the medical container 1 of this embodiment. In such a modified example, instead of providing the blocking member 13 for sliding on the bypass line 7, a clamp 51 which is a gripping jig that liquid-tightly closes the bypass line 7 is provided. Even with such a configuration, the operational effects of the present embodiment can be sufficiently exhibited.
【0029】次に図6乃至図10に従って本発明の第二
実施例の医療用容器21を詳述する。図6は本発明に係
る医療用容器の第二実施例の要部断面図、図7は第二実
施例の医療用容器に使用される連通針の側面図、図8
は、除菌フィルタを中央で支持する支持円柱の上面図及
び側面図、図9は第二実施例の医療用容器内の薬液を薬
剤容器に流入する際の要部側面図、図10は第二実施例
の医療用容器に薬剤容器から薬液を戻す際の要部断面図
である。Next, the medical container 21 according to the second embodiment of the present invention will be described in detail with reference to FIGS. FIG. 6 is a cross-sectional view of a main part of a second embodiment of the medical container according to the present invention, FIG. 7 is a side view of a communicating needle used in the medical container of the second embodiment, and FIG.
Is a top view and a side view of a supporting column for supporting the sterilization filter at the center, FIG. 9 is a side view of a main part when the drug solution in the medical container of the second embodiment flows into the drug container, and FIG. It is a principal part sectional view at the time of returning a chemical | medical solution from a chemical | medical agent container to the medical container of 2nd Example.
【0030】図6乃至図10に示す医療用容器21は、
容器本体22に除菌フィルタ8及び排出口が取付られる
点は第一実施例の医療用容器1と同様であるが、以下の
点が相違する。容器本体22の熱融着部22Aには、樹
脂成形物からなるパイプ状の取付口部23が液密に取付
られ、取付口部23には除菌フィルタ8の下部ハウジン
グ28Aが接続される。また取付口部23内には連通材
25が摺動可能に且つ液密に挿通され、連通材25は基
端に押部となるフランジ26と先端側壁に連通材25の
差し込み時に下方ハウジング28A内と連通しうる連通
開口27、27とが形成される。The medical container 21 shown in FIG. 6 to FIG.
The disinfection filter 8 and the discharge port are attached to the container body 22 as in the medical container 1 of the first embodiment, but the following points are different. A pipe-shaped attachment port 23 made of a resin molded product is liquid-tightly attached to the heat-sealing portion 22A of the container body 22, and the lower housing 28A of the sterilization filter 8 is connected to the attachment port 23. Further, the communication member 25 is slidably and liquid-tightly inserted into the mounting opening 23, and the communication member 25 has a flange 26 serving as a pressing portion at the base end and a communication member 25 inside the lower housing 28A when the communication member 25 is inserted into the tip side wall. Communication openings 27, 27 that are capable of communicating with are formed.
【0031】下部ハウジング28Aには除菌フィルタ8
の周縁を挟んで上部ハウジング28Bが熱融着され、上
部ハウジング28Bの中央部に支持円柱29が取付られ
る。支持円柱29の外周壁には接着剤を介して除菌フィ
ルタ8の中央部分が支持される。支持円柱29の中心部
には貫通路30が形成され、貫通路30には上記連通材
25及び連通材25に接続される連通針31が摺動可能
に且つ液密に挿通される。The lower housing 28A has a sterilizing filter 8
The upper housing 28B is heat-sealed with the peripheral edge of the upper housing 28B sandwiched therebetween, and the support column 29 is attached to the central portion of the upper housing 28B. The central portion of the sterilization filter 8 is supported on the outer peripheral wall of the support column 29 via an adhesive. A through passage 30 is formed at the center of the support column 29, and the communicating member 25 and the communicating needle 31 connected to the communicating member 25 are slidably and liquid-tightly inserted into the through passage 30.
【0032】図7(a)及び(b)に示す如く連通材2
5及び連通針31は樹脂成形物からなり、連通材25と
連通針31との外径は同じで、内部が互いに連通させず
に接続される。連通針31は基端に連通口32、32が
形成され、先端にも連通開口33、33が形成される。
また、連通針31の基端側面には突起部34、34が形
成される。連通口32は下方ハウジング28Aに連通す
る位置にあると共に、連通針31の押し込み時に後述の
支持円柱29の連通孔36に連通する。図8(a)及び
(b)に示す如く、支持円柱29の貫通路30には、半
径方向に一対の溝条部35、35が軸方向の中間まで設
けられ、溝条部35には連通針31の突起部34が挿通
可能となっている。また、溝条部35終端の位置から9
0°回転した位置に、貫通路30と外側面とを連通する
前述の連通孔36、36が形成される。従って、溝条部
35に突起部34が完全に挿通されたとき連通針31の
連通口32と支持円柱29の連通孔36が連絡され、支
持円柱29の外部と連通針31内とが連通するようにな
っている。As shown in FIGS. 7A and 7B, the communicating member 2
5 and the communicating needle 31 are made of a resin molded product, the communicating material 25 and the communicating needle 31 have the same outer diameter, and the insides thereof are connected without communicating with each other. The communication needle 31 has communication ports 32, 32 formed at its proximal end and communication openings 33, 33 also formed at its distal end.
In addition, projections 34, 34 are formed on the proximal side surface of the communication needle 31. The communication port 32 is located at a position where it communicates with the lower housing 28A, and also communicates with a communication hole 36 of the support column 29 described later when the communication needle 31 is pushed. As shown in FIGS. 8A and 8B, the through passage 30 of the support column 29 is provided with a pair of groove portions 35, 35 in the radial direction up to the middle in the axial direction, and communicates with the groove portion 35. The protrusion 34 of the needle 31 can be inserted. Also, from the position of the end of the groove portion 35,
The above-mentioned communication holes 36, 36 that communicate the through passage 30 and the outer side surface are formed at the position rotated by 0 °. Therefore, when the protrusion 34 is completely inserted into the groove portion 35, the communication port 32 of the communication needle 31 and the communication hole 36 of the support column 29 are communicated with each other, and the outside of the support column 29 and the inside of the communication needle 31 are communicated with each other. It is like this.
【0033】支持円柱29の上部には連通針31のキャ
ップを兼ねた薬剤容器40を支持する容器支持材37が
取付られる。容器支持材37は樹脂成形物からなり、連
通針31が貫通される上面が肉薄に形成されている。ま
た容器支持材37にはエア抜き或はエア導入用の針38
が設けられ、針38の基端にはエアフィルタ39が取付
られ、エア抜き用針38は、連通針31が薬剤容器のゴ
ム栓41に刺針されると同時に、同じように刺針され
る。図9に示す如く薬剤容器40は定型性のあるバイア
ルからなり、バイアル内には上述した第一実施例と同様
な薬剤が凍結乾燥により無菌充填され、ゴム栓41で密
封される。On the upper part of the supporting column 29, a container supporting member 37 for supporting the medicine container 40 which doubles as a cap of the communication needle 31 is attached. The container support member 37 is made of a resin molded product, and the upper surface through which the communication needle 31 penetrates is formed thin. Further, the container support member 37 has a needle 38 for bleeding air or introducing air.
Is provided, an air filter 39 is attached to the proximal end of the needle 38, and the air bleeding needle 38 is similarly punctured at the same time when the communication needle 31 is punctured by the rubber stopper 41 of the drug container. As shown in FIG. 9, the drug container 40 is composed of a typical vial, and the drug similar to that in the first embodiment described above is aseptically filled by freeze-drying and sealed with a rubber stopper 41.
【0034】次に、図9及び図10に従って本実施例の
医療用容器21の使用について説明する。先ず、医療用
容器21は転倒され、連通材25のフランジ26が容器
本体22の外側から下方に向けて押し込まれる。押し込
みにより、連通材25及び連通針31が摺動し、連通針
31の突起部34が支持円柱29面に当接される。また
かかる摺動により、予めセットされた薬剤容器40のゴ
ム栓41に連通針31が刺針され、連通針31内と薬剤
容器40内とが連通された状態となる。また、エア針3
8もゴム栓41に刺針された状態にされる。従って、容
器本体22内の薬液は、連通材25内、連通口27、連
通材25の外側とハウジング内側との隙間50、突起部
34の外側、連通針31の連通口32、連通針31内、
連通開口33を介して薬剤容器40内に所定量流入され
る。Next, the use of the medical container 21 of this embodiment will be described with reference to FIGS. 9 and 10. First, the medical container 21 is turned over, and the flange 26 of the communication member 25 is pushed downward from the outside of the container body 22. By pushing, the communication member 25 and the communication needle 31 slide, and the projection 34 of the communication needle 31 is brought into contact with the surface of the supporting column 29. Further, by such sliding, the communication needle 31 is pierced into the rubber stopper 41 of the medicine container 40 set in advance, and the inside of the communication needle 31 and the inside of the medicine container 40 are in communication with each other. Also, the air needle 3
8 is also in a state of being pierced by the rubber stopper 41. Therefore, the chemical liquid in the container body 22 is in the communication member 25, the communication port 27, the gap 50 between the outside of the communication member 25 and the inside of the housing, the outside of the protrusion 34, the communication port 32 of the communication needle 31, and the communication needle 31. ,
A predetermined amount is flown into the medicine container 40 through the communication opening 33.
【0035】薬液3の流入が完了し薬剤容器15内で薬
剤16と薬液3とが十分に混合された後、連通材25が
90°回転され、突起部34が支持円柱29の溝条部3
5に入れて更に挿入される。そして、図10に示す如
く、再び、容器本体22が薬剤容器40と共に転倒され
て配置される。従って、薬剤容器40内の薬液42は、
連通開口33、連通針31内、連通口32及び支持円柱
29を介してハウジング28B内に流入される。流入薬
液42は除菌フィルタ8を通過して連通口27及び連通
材25内より、容器本体2内に戻される。このような医
療用容器21では、薬液と薬剤と迅速に混合し、その混
合薬液42が除菌フィルタ8により無菌的に容器本体2
2内に戻る。After the inflow of the drug solution 3 is completed and the drug 16 and the drug solution 3 are sufficiently mixed in the drug container 15, the communicating member 25 is rotated 90 °, and the projection 34 is formed into the groove 3 of the supporting column 29.
It is put in 5 and inserted further. Then, as shown in FIG. 10, the container main body 22 is again arranged together with the medicine container 40 by being turned over. Therefore, the drug solution 42 in the drug container 40 is
It flows into the housing 28B through the communication opening 33, the communication needle 31, the communication port 32, and the support column 29. The inflowing chemical liquid 42 passes through the sterilization filter 8 and is returned to the inside of the container body 2 through the communication port 27 and the communication material 25. In such a medical container 21, a drug solution and a drug are rapidly mixed, and the mixed drug solution 42 is aseptically filtered by the sterilization filter 8.
Return to 2
【0036】尚、上記実施例では、エア抜き、エア導入
用のエアフィルタ付きエア針38をゴム栓41と連通さ
せたが、これに限るものではなく、連通針31に直接設
けても同様な効果が得られる。In the above embodiment, the air needle 38 with an air filter for air bleeding and air introduction is communicated with the rubber stopper 41, but the invention is not limited to this, and the same may be provided directly on the communication needle 31. The effect is obtained.
【0037】[0037]
【発明の効果】以上説明したように本発明に係る医療用
容器では、上記容器本体と薬剤容器とを連通させた連通
路に除菌フィルタが設けられると共に、上記除菌フィル
タを避けて上記容器本体内と薬剤容器内とを結ぶバイパ
ス路が設けられ、上記薬剤容器に上記連通手段で接続し
た際に、上記容器本体の薬液の一部が上記薬剤容器内に
バイパス路を介して流入しうると共に、再び上記薬液が
戻る際に、上記バイパス路が閉止しうるので、薬剤と薬
液とが迅速に混合され、無菌的に容器内に戻すことので
きる。As described above, in the medical container according to the present invention, the sterilization filter is provided in the communication passage that connects the container body and the drug container, and the container is avoided by avoiding the sterilization filter. A bypass path connecting the main body and the inside of the drug container is provided, and when the drug container is connected by the communication means, a part of the drug solution in the container body may flow into the drug container via the bypass path. At the same time, when the drug solution returns again, the bypass passage can be closed, so that the drug and the drug solution can be rapidly mixed and aseptically returned to the container.
【図1】本発明に係る医療用容器の第一実施例の正断面
図FIG. 1 is a front sectional view of a first embodiment of a medical container according to the present invention.
【図2】第一実施例の医療用容器に接続される薬剤容器
の正断面図である。FIG. 2 is a front sectional view of a drug container connected to the medical container of the first embodiment.
【図3】第一実施例の医療用容器を薬剤容器に接続して
薬液を薬剤容器に流入する際の要部断面図である。FIG. 3 is a cross-sectional view of essential parts when the medical container of the first embodiment is connected to a drug container and a drug solution flows into the drug container.
【図4】薬剤容器内の薬液を再び第一実施例の医療用容
器内に再び流入する際の要部断面図である。FIG. 4 is a cross-sectional view of essential parts when the drug solution in the drug container again flows into the medical container of the first embodiment.
【図5】第一実施例の医療用容器の変形例を示す図であ
る。FIG. 5 is a diagram showing a modification of the medical container according to the first embodiment.
【図6】本発明に係る医療用容器の第二実施例の要部断
面図である。FIG. 6 is a cross-sectional view of essential parts of a second embodiment of the medical container according to the present invention.
【図7】図1の薬剤容器から輸液容器へ混合液を戻す際
の第一実施例の除菌フィルタの断面図である。FIG. 7 is a cross-sectional view of the sterilization filter of the first embodiment when returning the mixed liquid from the medicine container of FIG. 1 to the infusion container.
【図8】本発明の第二実施例の除菌フィルタ付きの輸液
容器の正面図である。FIG. 8 is a front view of an infusion container with a sterilization filter according to a second embodiment of the present invention.
【図9】図7の除菌フィルタ付きの輸液容器に用いられ
る除菌フィルタ構造の部材を示す図である。FIG. 9 is a view showing a member of a disinfection filter structure used in the infusion container with the disinfection filter of FIG. 7.
【図10】第二実施例の除菌フィルタ構造に使用される
機能性フィルタの斜視図である。FIG. 10 is a perspective view of a functional filter used in the disinfection filter structure of the second embodiment.
1 医療用容器 2 容器本体 3 薬液 4 排出口 6 連通パイプ 7 バイパスライン 8 除菌フィルタ 9 ハウジング 10 連通路 10A 連通路の連通針部 13 遮断部材 15 薬剤容器 16 薬剤 1 Medical Container 2 Container Body 3 Chemical Solution 4 Discharge Port 6 Communication Pipe 7 Bypass Line 8 Sterilization Filter 9 Housing 10 Communication Passage 10A Communication Needle Portion of Communication Passage 13 Blocking Member 15 Drug Container 16 Drug
Claims (8)
の樹脂容器本体からなり、且つ上記容器本体内の薬液の
一部が薬剤容器内に流入されて該薬剤と混合された後、
再び該薬液が上記容器本体内に戻される医療用容器にお
いて、 上記容器本体と薬剤容器とを連通させた連通路に除菌フ
ィルタが設けられると共に、上記除菌フィルタを避けて
上記容器本体内と薬剤容器内とを結ぶバイパス路が設け
られ、 上記薬剤容器に上記連通手段で接続した際に、上記容器
本体の薬液の一部が上記薬剤容器内にバイパス路を介し
て流入しうると共に、再び上記薬液が戻る際に、上記バ
イパス路が閉止しうることを特徴とする医療用容器。1. An atypical resin container body having a means for communicating with a drug container, wherein a part of the drug solution in the container body flows into the drug container and is mixed with the drug,
In the medical container in which the drug solution is returned to the container body again, a sterilizing filter is provided in a communication passage that connects the container body and the drug container, and the sterilizing filter is avoided to be in the container body. A bypass path connecting the inside of the drug container is provided, and when connected to the drug container by the communication means, a part of the drug solution in the container body may flow into the drug container via the bypass path and again. A medical container characterized in that the bypass passage can be closed when the drug solution returns.
連通するバイパスラインからなり、該ラインが除菌フィ
ルタと上記薬剤容器との間の連通路に接続されているこ
とを特徴とする請求項1記載の医療用容器。2. The bypass passage is composed of a bypass line that directly communicates with the container body, and the line is connected to a communication passage between the sterilization filter and the drug container. 1. The medical container according to 1.
材が上記連通路に設けられることを特徴とする請求項2
記載の医療用容器。3. A blocking member for opening and closing the bypass line is provided in the communication passage.
The medical container described.
からなり、把持治具により液密に閉止されうるものであ
ることを特徴とする請求項2記載の医療用容器。4. The medical container according to claim 2, wherein the bypass line is made of a flexible line and can be liquid-tightly closed by a holding jig.
能に取付けられる連通材からなり、上記連通材は、先端
に上記薬剤容器に連通する連通針部が設けられ、該連通
材の所定量の移動により上記針部が上記薬剤容器へ刺針
すると共に、上記容器本体内と薬剤容器とが直接連通す
ることを特徴とする請求項1記載の医療用容器。5. The bypass passage is made of a communicating material that is movably attached to the communicating passage, and the communicating material has a communicating needle portion at a tip thereof that communicates with the medicine container, and a predetermined amount of the communicating material. The medical container according to claim 1, wherein the needle portion punctures the drug container by the movement of the container, and the inside of the container body and the drug container are directly communicated with each other.
器であることを特徴とする請求項1乃至5のいずれかに
記載の医療用容器。6. The medical container according to claim 1, wherein the drug container is an atypical resin container.
って、上記薬剤容器或は上記連通路に外部と連通するエ
ア抜けエア導入開口が形成されると共に、該開口にエア
フィルタが設けられることを特徴とする請求項1乃至5
のいずれかに記載の医療用容器。7. The medicine container is a container having a regularity, and an air escape air introduction opening communicating with the outside is formed in the medicine container or the communication passage, and an air filter is provided in the opening. 6. The method according to claim 1, wherein
The medical container according to any one of 1.
ぶ連通路の連通口が上記容器本体内の排出口付近に配さ
れていることを特徴とする請求項1乃至7記載いずれか
に記載の医療用容器。8. The communication port of a communication path connecting the sterilization filter and the container body is arranged near the discharge port in the container body. Medical container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7070686A JPH08238299A (en) | 1995-03-03 | 1995-03-03 | Medical container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7070686A JPH08238299A (en) | 1995-03-03 | 1995-03-03 | Medical container |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08238299A true JPH08238299A (en) | 1996-09-17 |
Family
ID=13438785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7070686A Pending JPH08238299A (en) | 1995-03-03 | 1995-03-03 | Medical container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH08238299A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091694A1 (en) * | 2000-06-01 | 2001-12-06 | Mitsubishi Pharma Corporaion | Plug-equipped liquid medicine container |
RU2743609C1 (en) * | 2020-08-06 | 2021-02-20 | Общество с ограниченной ответственностью "Научно-производственное предприятие Биотех-М" | Double container for hemocomponents and method for using it |
RU2749633C1 (en) * | 2020-07-09 | 2021-06-16 | Общество с ограниченной ответственностью "ГЕМОДЖЕНИКС" | System for lyophilization, storage and use of biological material |
-
1995
- 1995-03-03 JP JP7070686A patent/JPH08238299A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091694A1 (en) * | 2000-06-01 | 2001-12-06 | Mitsubishi Pharma Corporaion | Plug-equipped liquid medicine container |
RU2749633C1 (en) * | 2020-07-09 | 2021-06-16 | Общество с ограниченной ответственностью "ГЕМОДЖЕНИКС" | System for lyophilization, storage and use of biological material |
RU2743609C1 (en) * | 2020-08-06 | 2021-02-20 | Общество с ограниченной ответственностью "Научно-производственное предприятие Биотех-М" | Double container for hemocomponents and method for using it |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5662642A (en) | Instillator with medicator-connecting mouth | |
US11759395B2 (en) | Dual container system for product reconstitution | |
JPH05212090A (en) | Transfusion container | |
US11974966B2 (en) | Medical product including pre-filled product bag | |
US6773427B2 (en) | Infusion container | |
JPH07213585A (en) | Admixture injection adapter | |
JP2009178584A (en) | Chemical liquid injection port, and chemical liquid container having the same | |
JPH08238299A (en) | Medical container | |
JPH08141049A (en) | Connecting part for mixing medicine and its container with the same | |
JPH09173416A (en) | Manufacture of medical container | |
JPH0919480A (en) | Medical vessel | |
JP2004290218A (en) | Multi-cell bag containing medicine and port member | |
JPH0975425A (en) | Medical vessel | |
JPH07171192A (en) | Infusion vessel | |
JPH0928765A (en) | Mouth part structure for medical container and assembling method therefor | |
JPH08257098A (en) | Medical vessel with germ removing filter | |
EP3655067A1 (en) | Medical syringe system with filtered filling port | |
JPH0956779A (en) | Mouth structure of medical container | |
JPH08243149A (en) | Filter supporting structure | |
JPH08280802A (en) | Injecting syringe | |
JPH08196875A (en) | Structure of microbe eliminating filter | |
JPH07112015A (en) | Liquid communicating tube | |
JPH08276010A (en) | Injector | |
JPH08332225A (en) | Syringe | |
JPH0928796A (en) | Transport liquid tool |